Melanoma Surveillance in the US: Melanoma, Ultraviolet Radiation, and Socioeconomic Status

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast from the Centers for Disease Control and Prevention, Chris Johnson, from the Cancer Data Registry of Idaho, discusses the results of several studies published in a supplement to the November 2011 edition of the Journal of the American Academy of Dermatology that examined the relationship between rates of melanoma and 2 variables recorded at the county level: ultraviolet radiation and socioeconomic status.
 
To listen to the podcast, click here.
Related Articles
A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.
The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.
RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.
Latest Issues
$auto_registration$